Late-breaking abstract: Inhibition of Pim1 kinase augments the anti-viral response to rhinovirus infection

作者
Maaike de Vries,Nicole Bedke,Natalie P. Smithers,Peter Hugo Howarth,Martijn C. Nawijn,Donna E. Davies
出处
期刊:The European respiratory journal [European Respiratory Society]
卷期号:44 (Suppl 58): P519-P519
标识
DOI:10.1183/13993003/erj.44.suppl_58.p519
摘要

Asthma is a chronic inflammatory disease characterized by reversible airflow obstruction and bronchial hyperreactivity. Asthmatic patients frequently suffer from exacerbations, mainly triggered by viral infections, and therapeutic options are limited. The anti-viral response in asthmatic patients is compromised and factors augmenting this response could offer new therapeutic approaches. Here, we hypothesized that Pim1 kinase, known to stabilize SOCS-proteins that interfere with interferon signalling, could be such a new therapeutic target. Air-liquid interface (ALI) cultures of primary bronchial epithelial cells (PBEC) were exposed to rhinovirus (RV16) without or with pharmacological inhibition of Pim1 kinase. Viral replication and viral load were measured by qPCR and HeLa cell titration assay. Anti-viral responses were measured by analysing IFN-β, IL-29, IP-10 and RANTES expression. Protein levels of SOCS-3 and p-STAT1 were determined by Western Blotting. Inhibition of Pim1 kinase significantly reduced viral replication in ALI cultures of healthy volunteers, which was accompanied by an increase in anti-viral responses 12 hours after RV16 infection. Although no difference in SOCS-3 levels were detectable, STAT1 phosphorylation was higher in RV16-infected PBECs when Pim1 kinase activity was inhibited. A comparable reduction in viral infection and increase in anti-viral responses was observed in ALI cultures of severe asthmatics. In conclusion, our data suggest that Pim1 kinase facilitates viral replication by suppressing anti-viral signalling. The therapeutic potential of Pim1 kinase inhibition for treatment of viral-induced asthma exacerbations should be further explored.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
film完成签到 ,获得积分10
2秒前
arch完成签到,获得积分10
3秒前
酷炫大白完成签到,获得积分10
3秒前
兰先生完成签到,获得积分10
3秒前
欣喜烙完成签到 ,获得积分10
4秒前
4秒前
机智铭完成签到,获得积分10
5秒前
龙阿完成签到 ,获得积分10
6秒前
111完成签到,获得积分20
7秒前
小劳完成签到,获得积分10
8秒前
LIUJIE完成签到,获得积分10
8秒前
8秒前
活泼雪莲发布了新的文献求助10
8秒前
冬草完成签到,获得积分10
9秒前
情怀的应助被Benthesikyme采纳,获得10
9秒前
qaplay完成签到 ,获得积分0
9秒前
看文献完成签到,获得积分10
10秒前
chenying完成签到 ,获得积分0
14秒前
shuang完成签到,获得积分10
15秒前
15秒前
我就是KKKK完成签到,获得积分10
16秒前
gsxgg完成签到,获得积分10
18秒前
21秒前
快乐的小木虫完成签到,获得积分10
21秒前
csy完成签到,获得积分10
22秒前
fangyuan完成签到,获得积分10
23秒前
郑琦敏钰完成签到 ,获得积分10
24秒前
davyean完成签到,获得积分10
24秒前
aaa完成签到,获得积分10
24秒前
淡淡依霜完成签到 ,获得积分10
26秒前
辣条我有呀完成签到 ,获得积分10
26秒前
jiangsi完成签到 ,获得积分10
27秒前
酷炫的大碗完成签到,获得积分10
27秒前
Daisy完成签到 ,获得积分10
28秒前
执着的天使完成签到 ,获得积分10
29秒前
生动的乐曲完成签到,获得积分10
29秒前
ChengYonghui完成签到,获得积分10
30秒前
火星上蜜粉完成签到,获得积分10
31秒前
树妖三三完成签到,获得积分10
32秒前
32秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166556
求助须知:如何正确求助?哪些是违规求助? 9559576
关于积分的说明 21750809
捐赠科研通 7757392
什么是DOI,文献DOI怎么找? 3429167
关于科研通互助平台的介绍 2553530
邀请新用户注册赠送积分活动 2473923